Relmada purchases Sepranolone, a Phase 2b ready asset, for the treatment of Tourette syndrome (TS) and other compulsion-related conditions from Asarina Pharma AB Phase 2a results signaled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback